Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-05 Watanabe Todd Franklin President and CEO Sale −1,000 $21.76 $22K 658,667
2022-05-02 Welgus Howard G. Director Exercise or conversion +1,496 $0.58 $868 183,392
2022-05-02 Welgus Howard G. Director Exercise or conversion +1,004 $1.68 $2K 184,396
2022-05-02 Welgus Howard G. Director Sale −2,500 $20.44 $51K 181,896
2022-05-02 Welgus Howard G. Director Exercise or conversion · Stock Option (Right to Buy) −1,496 6,110
2022-05-02 Welgus Howard G. Director Exercise or conversion · Stock Option (Right to Buy) −1,004 43,978
2022-04-21 OSBORNE DAVID W Chief Technical Officer Sale −2,197 $20.42 $45K 257,229
2022-04-08 ORBIMED ADVISORS LLC 10% owner Sale −97,200 $20.71 $2.0M 3,840,564
2022-04-08 ORBIMED ADVISORS LLC 10% owner Sale −102,800 $20.71 $2.1M 451,086
2022-04-07 ORBIMED ADVISORS LLC 10% owner Sale −167,800 $20.66 $3.5M 3,937,764
2022-04-07 ORBIMED ADVISORS LLC 10% owner Sale −177,196 $20.66 $3.7M 553,886
2022-04-06 ORBIMED ADVISORS LLC 10% owner Sale −162,000 $20.69 $3.4M 4,105,564
2022-04-06 ORBIMED ADVISORS LLC 10% owner Sale −171,204 $20.69 $3.5M 731,082
2022-04-05 Watanabe Todd Franklin President and CEO Sale −1,000 $21.43 $21K 659,667
2022-04-01 Welgus Howard G. Director Exercise or conversion +7,500 $0.58 $4K 189,396
2022-04-01 Welgus Howard G. Director Sale −7,500 $20.02 $150K 181,896
2022-04-01 Welgus Howard G. Director Exercise or conversion · Stock Option (Right to Buy) −7,500 7,606
2022-03-23 Turney Patricia A. SVP, Operations Exercise or conversion +15,331 $6.52 $100K 46,444
2022-03-23 Turney Patricia A. SVP, Operations Exercise or conversion · Stock Option (Right to Buy) −15,331 144,612
2022-03-23 Turney Patricia A. SVP, Operations Exercise or conversion +25,328 $6.52 $165K 56,441

Page 30 of 35 · 689 trades